MedPath

Study Targeting Affect Regulation

Phase 1
Completed
Conditions
Substance Use Disorders
HIV
AIDS
Interventions
Behavioral: Resilient Affective Processing Therapy (RAPT)
Registration Number
NCT01237366
Lead Sponsor
University of California, San Francisco
Brief Summary

This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who have sex with men (MSM). Following a baseline assessment, 56 participants will be randomized to receive either: 1) a 7-session intervention to address traumatic stress related to living with HIV/AIDS; or 2) a 7-session, attention-control condition. Follow-up assessments will be administered at 1 and 3 months post-randomization.

Detailed Description

In the multi-component intervention protocol, participants will complete expressive writing exercises where they will be asked to write about difficult life experiences. Following expressive writing, participants will receive stress management skills training to assist them with managing any acute increases in distress that arise from the writing experience. Participants in the attention-control condition will write about neutral topics and complete psychological measures. The overarching goals of this Phase Ib RCT will be to: 1) examine the feasibility and acceptability of the intervention and attention-control; and 2) determine whether intervention participants report reductions in traumatic stress symptoms over the 3 months following randomization. Findings from this Phase Ib trial will inform our efforts to implement a more definitive RCT of this intervention with HIV-positive, methamphetamine-using MSM.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
56
Inclusion Criteria
  • 18 years of age or older
  • Speak English
  • Self-identify as a man who has sex with men
  • Have been diagnosed with HIV for at least 3 months
  • Provide evidence of HIV-positive serostatus
  • Report using methamphetamine during the past 30 days
Read More
Exclusion Criteria
  • Do not have the capacity to provide informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Reslient Affective Processing Therapy (RAPT)Resilient Affective Processing Therapy (RAPT)-
Primary Outcome Measures
NameTimeMethod
Traumatic stress symptom severity3-month follow-up

Our team will use the Impact of Event Scale to measure the self-reported severity of traumatic stress symptoms related to HIV/AIDS.

Secondary Outcome Measures
NameTimeMethod
Psychological reactivity to expressive writing1-month follow-up

Participants will complete measures of subjective distress and craving of stimulants (i.e., methamphetamine, cocaine, and crack) before and after each expressive writing exercise to provide an index of habituation. Habituation is defined as a 50% reduction in the psychological reactivity to the expressive writing experience using these self-report measures.

Trial Locations

Locations (1)

UCSF Center for AIDS Prevention Studies

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath